Abstract
Syrian hamsters were treated with ethinylestradiol and maintained on a diet containing alpha-naphthoflavone (alpha NF), a regimen that produces a high incidence of liver tumors. Morphologic analyses (light microscopy, immunoperoxidase studies, and electron microscopy) were performed on livers of these animals. After 4 months of hormone plus alpha NF treatment, marked hepatocyte cell changes were already present, as demonstrated by loss of eosinophilic staining of hepatocyte cytoplasm. Large multinucleated hepatocytes exhibiting frequent mitoses were observed around central veins. After 5 months of treatment, there was proliferation of bile ducts, and small cells with eosinophilic cytoplasm resembling hepatocytes appeared surrounding these bile ducts. At 7 to 8 months, the first tumor nodules (foci) were seen. Tumor foci in the portal area consisted of small clusters of large cells resembling hepatocytes with irregular nuclei. At the same time, dysplastic glands were identified among proliferating bile ducts. By 8 to 10 months, large tumors were present. These were trabecular hepatocellular carcinomas with widely varying individual cell morphology. Compared with adjacent liver, dysplastic glands in the portal areas, microcarcinomas, and large tumors all showed intense immunostaining for cytokeratin. Rats treated with the same regimen also developed hepatic tumors, but the light and electron microscopy results and immunohistochemical profiles were very different. Altered hepatic foci composed of small hepatocytes were typically prominent; however, malignant tumors did not arise from the portal area. Neither altered foci nor tumors stained significantly for cytokeratin. These data suggest that the biochemical events giving rise to these liver tumors differ between the species studied, despite the animals being exposed to the same treatment regimens.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chisari F. V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H. A., Sell S., Pinkert C. A., Brinster R. L., Palmiter R. D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989 Dec 22;59(6):1145–1156. doi: 10.1016/0092-8674(89)90770-8. [DOI] [PubMed] [Google Scholar]
- Gonzalez A., Oberley T. D., Li J. J. Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: probable cell of origin. Cancer Res. 1989 Feb 15;49(4):1020–1028. [PubMed] [Google Scholar]
- Kinoshita N., Gelboin H. V. Aryl hydrocarbon hydroxylase and polycyclic hydrocarbon tumorigenesis: effect of the enzyme inhibitor 7,8-benzoflavone on tumorigenesis and macromolecule binding. Proc Natl Acad Sci U S A. 1972 Apr;69(4):824–828. doi: 10.1073/pnas.69.4.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li J. J., Li S. A. Estrogen carcinogenesis in hamster tissues: a critical review. Endocr Rev. 1990 Nov;11(4):524–531. doi: 10.1210/edrv-11-4-524. [DOI] [PubMed] [Google Scholar]
- Li J. J., Li S. A. High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed alpha-naphthoflavone: a new tumor model. J Natl Cancer Inst. 1984 Aug;73(2):543–547. doi: 10.1093/jnci/73.2.543. [DOI] [PubMed] [Google Scholar]
- Netter K. J. Inhibition of oxidative drug metabolism in microsomes. Pharmacol Ther. 1980;10(3):515–535. doi: 10.1016/0163-7258(80)90029-7. [DOI] [PubMed] [Google Scholar]
- Oberley T. D., Gonzalez A., Lauchner L. J., Oberley L. W., Li J. J. Characterization of early kidney lesions in estrogen-induced tumors in the Syrian hamster. Cancer Res. 1991 Apr 1;51(7):1922–1929. [PubMed] [Google Scholar]
- Sell S., Dunsford H. A. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol. 1989 Jun;134(6):1347–1363. [PMC free article] [PubMed] [Google Scholar]
- Slaga T. J., Thompson S., Berry D. L., Digiovanni J., Juchau M. R., Viaje A. The effects of benzoflavones on polycyclic hydrocarbon metabolism and skin tumor initiation. Chem Biol Interact. 1977 Jun;17(3):297–312. doi: 10.1016/0009-2797(77)90093-x. [DOI] [PubMed] [Google Scholar]